Literature DB >> 1685993

Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.

E V Sørensen1, H K Jensen, O Faergeman.   

Abstract

The influence of clinical doses of drugs that affect beta-adrenoceptors has been examined on heart rate, blood pressure, duration of exercise, and on electrolyte concentrations (Na, K, Ca and Mg) during recovery from exercise in healthy volunteers. The drugs used were a beta 1-adrenoceptor antagonist atenolol, a nonselective beta-adrenoceptor antagonist propranolol, and a cardioselective, partial beta 1-adrenoceptor agonist with 43% ISA activity, xamoterol. The duration of exercise was smaller on propranolol. Maximum exercise heart rate and blood pressure were reduced significantly by propranolol and atenolol. Xamoterol reduced maximum exercise heart rate and had no effect on blood pressure. The degree of breathlessness and fatigue revealed no differences between treatments. Recent evidence has suggested an association between hyperkalaemia and hypomagnesaemia with an increase in the occurrence of arrythmias following acute myocardial infarction. Exercise-induced hyperkalaemia has been suggested as a factor in sudden death. The results confirmed a rise in serum potassium during exercise and attenuation of the fall during recovery under beta-adrenoceptor blockade. Xamoterol was no different from placebo in these respects. Exercise also produced a rise in magnesium levels and during recovery the level fell below baseline. Both these effects were attenuated by propranolol. Calcium levels were not affected by any of the treatments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685993     DOI: 10.1007/BF00280106

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  The action of adrenaline on serum potassium.

Authors:  J L D'Silva
Journal:  J Physiol       Date:  1934-11-12       Impact factor: 5.182

Review 2.  The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.

Authors:  H M Snow
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

3.  A Symposium: Potassium, catecholamines and beta blockade. June 22-23, 1984, New York, New York.

Authors: 
Journal:  Am J Cardiol       Date:  1985-08-30       Impact factor: 2.778

4.  Hypokalemia from beta 2-receptor stimulation by circulating epinephrine.

Authors:  M J Brown
Journal:  Am J Cardiol       Date:  1985-08-30       Impact factor: 2.778

5.  The selectivity of the beta-adrenoceptor for ventilation in man.

Authors:  R J Butland; J A Pang; D M Geddes
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

6.  Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol.

Authors:  G Jennings; A Bobik; C Oddie; R Restall
Journal:  Clin Pharmacol Ther       Date:  1984-05       Impact factor: 6.875

7.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

8.  Thiazide-induced hypokalemia. Association with acute myocardial infarction and ventricular fibrillation.

Authors:  M Duke
Journal:  JAMA       Date:  1978-01-02       Impact factor: 56.272

9.  The effects of beta-adrenoceptor blockade on breathing during progressive exercise in normal man.

Authors:  S B Pearson; J F Morrison; F G Simpson
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

10.  The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man.

Authors:  A D Struthers; J L Reid; R Whitesmith; J C Rodger
Journal:  Clin Sci (Lond)       Date:  1983-08       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.